These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 10348091)

  • 1. Comparative tolerability of second generation antihistamines.
    Horak F; Stübner UP
    Drug Saf; 1999 May; 20(5):385-401. PubMed ID: 10348091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
    Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
    Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations among non-sedating antihistamines: are there real differences?
    Mattila MJ; Paakkari I
    Eur J Clin Pharmacol; 1999 Apr; 55(2):85-93. PubMed ID: 10335901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of antihistamines in children.
    Ten Eick AP; Blumer JL; Reed MD
    Drug Saf; 2001; 24(2):119-47. PubMed ID: 11235817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic overview of oral second-generation H1 antihistamines.
    González MA; Estes KS
    Int J Clin Pharmacol Ther; 1998 May; 36(5):292-300. PubMed ID: 9629995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-generation antihistamines: a comparative review.
    Slater JW; Zechnich AD; Haxby DG
    Drugs; 1999 Jan; 57(1):31-47. PubMed ID: 9951950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H1-receptor antagonists. Comparative tolerability and safety.
    Simons FE
    Drug Saf; 1994 May; 10(5):350-80. PubMed ID: 7913608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H1-receptor antagonists: safety issues.
    Estelle F; Simons R
    Ann Allergy Asthma Immunol; 1999 Nov; 83(5):481-8. PubMed ID: 10582735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsedating H1 antihistamines in chronic urticaria.
    Monroe EW
    Ann Allergy; 1993 Dec; 71(6):585-91. PubMed ID: 7903515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihistamine activity, central nervous system and cardiovascular profiles of histamine H1 antagonists: comparative studies with loratadine, terfenadine and sedating antihistamines in guinea-pigs.
    Hey JA; Del Prado M; Cuss FM; Egan RW; Sherwood J; Lin CC; Kreutner W
    Clin Exp Allergy; 1995 Oct; 25(10):974-84. PubMed ID: 8556569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsedating histamine H1-receptor antagonists.
    Mann KV; Crowe JP; Tietze KJ
    Clin Pharm; 1989 May; 8(5):331-44. PubMed ID: 2568212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-generation antihistamines: the risk of ventricular arrhythmias.
    DuBuske LM
    Clin Ther; 1999 Feb; 21(2):281-95. PubMed ID: 10211532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of antihistamines in the treatment of allergic rhinitis in elderly patients.
    McCue JD
    Arch Fam Med; 1996 Sep; 5(8):464-8. PubMed ID: 8797551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular toxicity of antihistamines.
    Smith SJ
    Otolaryngol Head Neck Surg; 1994 Sep; 111(3 Pt 2):348-54. PubMed ID: 7916150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsedating antihistamines: pharmacology, clinical efficacy and adverse effects.
    Kaliner MA
    Am Fam Physician; 1992 Mar; 45(3):1337-42. PubMed ID: 1347437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of second generation histamine antagonists on the heart].
    Grzelewska-Rzymowska I; Pietrzkowicz M; Górska M
    Pneumonol Alergol Pol; 2001; 69(3-4):217-26. PubMed ID: 11575008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs.
    de Abajo FJ; Rodríguez LA
    Br J Clin Pharmacol; 1999 Mar; 47(3):307-13. PubMed ID: 10215756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of second generation antihistamines.
    Philpot EE
    Allergy Asthma Proc; 2000; 21(1):15-20. PubMed ID: 10748947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic optimisation of histamine H1-receptor antagonist therapy.
    Simons FE; Simons KJ
    Clin Pharmacokinet; 1991 Nov; 21(5):372-93. PubMed ID: 1685361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic.
    Verster JC; Volkerts ER
    Ann Allergy Asthma Immunol; 2004 Mar; 92(3):294-303; quiz 303-5, 355. PubMed ID: 15049392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.